nodes	percent_of_prediction	percent_of_DWPC	metapath
Estramustine—ABCB1—esophageal cancer	0.602	1	CbGaD
Estramustine—MAP1A—bronchus—esophageal cancer	0.0111	0.093	CbGeAlD
Estramustine—MAP1A—smooth muscle tissue—esophageal cancer	0.0109	0.091	CbGeAlD
Estramustine—MAP1A—trachea—esophageal cancer	0.00997	0.0835	CbGeAlD
Estramustine—MAP2—neck—esophageal cancer	0.00941	0.0789	CbGeAlD
Estramustine—MAP1A—lung—esophageal cancer	0.00716	0.06	CbGeAlD
Estramustine—MAP2—bronchus—esophageal cancer	0.00631	0.0529	CbGeAlD
Estramustine—ESR2—neck—esophageal cancer	0.0061	0.0511	CbGeAlD
Estramustine—MAP2—trachea—esophageal cancer	0.00566	0.0475	CbGeAlD
Estramustine—MAP1A—lymph node—esophageal cancer	0.0049	0.0411	CbGeAlD
Estramustine—MAP2—digestive system—esophageal cancer	0.00487	0.0408	CbGeAlD
Estramustine—ESR1—neck—esophageal cancer	0.00418	0.035	CbGeAlD
Estramustine—ESR2—epithelium—esophageal cancer	0.00415	0.0348	CbGeAlD
Estramustine—MAP2—lung—esophageal cancer	0.00407	0.0341	CbGeAlD
Estramustine—ESR2—smooth muscle tissue—esophageal cancer	0.004	0.0335	CbGeAlD
Estramustine—Myelosuppression—Cisplatin—esophageal cancer	0.0039	0.0409	CcSEcCtD
Estramustine—Gastrointestinal tract irritation—Capecitabine—esophageal cancer	0.00378	0.0396	CcSEcCtD
Estramustine—Congenital anomaly—Capecitabine—esophageal cancer	0.00355	0.0372	CcSEcCtD
Estramustine—Developmental delay—Capecitabine—esophageal cancer	0.00355	0.0372	CcSEcCtD
Estramustine—ESR2—digestive system—esophageal cancer	0.00316	0.0265	CbGeAlD
Estramustine—Hoarseness—Capecitabine—esophageal cancer	0.00307	0.0321	CcSEcCtD
Estramustine—ESR1—epithelium—esophageal cancer	0.00284	0.0238	CbGeAlD
Estramustine—MAP2—lymph node—esophageal cancer	0.00278	0.0233	CbGeAlD
Estramustine—ESR1—smooth muscle tissue—esophageal cancer	0.00274	0.023	CbGeAlD
Estramustine—ESR2—lung—esophageal cancer	0.00264	0.0221	CbGeAlD
Estramustine—Night sweats—Capecitabine—esophageal cancer	0.0025	0.0262	CcSEcCtD
Estramustine—Ethinyl Estradiol—NR1I2—esophageal cancer	0.00229	0.206	CrCbGaD
Estramustine—Raised liver function tests—Methotrexate—esophageal cancer	0.00217	0.0228	CcSEcCtD
Estramustine—ESR1—digestive system—esophageal cancer	0.00216	0.0181	CbGeAlD
Estramustine—Embolism—Capecitabine—esophageal cancer	0.0021	0.022	CcSEcCtD
Estramustine—Tenderness—Cisplatin—esophageal cancer	0.0021	0.022	CcSEcCtD
Estramustine—Hypercalcaemia—Capecitabine—esophageal cancer	0.00194	0.0204	CcSEcCtD
Estramustine—ESR1—lung—esophageal cancer	0.00181	0.0151	CbGeAlD
Estramustine—ESR2—lymph node—esophageal cancer	0.0018	0.0151	CbGeAlD
Estramustine—Skin exfoliation—Cisplatin—esophageal cancer	0.00175	0.0183	CcSEcCtD
Estramustine—Dysphonia—Capecitabine—esophageal cancer	0.00164	0.0172	CcSEcCtD
Estramustine—Embolism—Methotrexate—esophageal cancer	0.00156	0.0164	CcSEcCtD
Estramustine—Estradiol—NR1I2—esophageal cancer	0.00151	0.136	CrCbGaD
Estramustine—Cardiac failure congestive—Cisplatin—esophageal cancer	0.00146	0.0154	CcSEcCtD
Estramustine—Lacrimation increased—Capecitabine—esophageal cancer	0.00146	0.0153	CcSEcCtD
Estramustine—Cerebrovascular accident—Cisplatin—esophageal cancer	0.00136	0.0142	CcSEcCtD
Estramustine—Gastrointestinal haemorrhage—Cisplatin—esophageal cancer	0.00133	0.0139	CcSEcCtD
Estramustine—Skin exfoliation—Capecitabine—esophageal cancer	0.00129	0.0135	CcSEcCtD
Estramustine—ESR1—lymph node—esophageal cancer	0.00124	0.0104	CbGeAlD
Estramustine—CYP3A4—digestive system—esophageal cancer	0.00121	0.0101	CbGeAlD
Estramustine—Estrone—CYP1B1—esophageal cancer	0.00115	0.103	CrCbGaD
Estramustine—Thrombophlebitis—Capecitabine—esophageal cancer	0.00113	0.0119	CcSEcCtD
Estramustine—ABCB1—epithelium—esophageal cancer	0.00112	0.00941	CbGeAlD
Estramustine—Abdominal discomfort—Cisplatin—esophageal cancer	0.0011	0.0115	CcSEcCtD
Estramustine—Pancytopenia—Cisplatin—esophageal cancer	0.00109	0.0114	CcSEcCtD
Estramustine—Eye pain—Capecitabine—esophageal cancer	0.00108	0.0114	CcSEcCtD
Estramustine—Libido decreased—Capecitabine—esophageal cancer	0.00106	0.0111	CcSEcCtD
Estramustine—Hot flush—Capecitabine—esophageal cancer	0.00105	0.011	CcSEcCtD
Estramustine—Menopausal symptoms—Capecitabine—esophageal cancer	0.00104	0.0109	CcSEcCtD
Estramustine—Thirst—Capecitabine—esophageal cancer	0.00103	0.0108	CcSEcCtD
Estramustine—Ethinyl Estradiol—ABCC2—esophageal cancer	0.00103	0.0922	CrCbGaD
Estramustine—Acute coronary syndrome—Cisplatin—esophageal cancer	0.00101	0.0106	CcSEcCtD
Estramustine—Myocardial infarction—Cisplatin—esophageal cancer	0.001	0.0105	CcSEcCtD
Estramustine—Cerebrovascular accident—Capecitabine—esophageal cancer	0.000999	0.0105	CcSEcCtD
Estramustine—Lethargy—Capecitabine—esophageal cancer	0.000999	0.0105	CcSEcCtD
Estramustine—ABCB1—trachea—esophageal cancer	0.000993	0.00832	CbGeAlD
Estramustine—Gastrointestinal haemorrhage—Capecitabine—esophageal cancer	0.000979	0.0103	CcSEcCtD
Estramustine—Disturbance in sexual arousal—Capecitabine—esophageal cancer	0.000971	0.0102	CcSEcCtD
Estramustine—Skin exfoliation—Methotrexate—esophageal cancer	0.000959	0.01	CcSEcCtD
Estramustine—Cardiac arrest—Capecitabine—esophageal cancer	0.000931	0.00976	CcSEcCtD
Estramustine—Mood swings—Capecitabine—esophageal cancer	0.000928	0.00972	CcSEcCtD
Estramustine—Liver function test abnormal—Capecitabine—esophageal cancer	0.000904	0.00948	CcSEcCtD
Estramustine—Gynaecomastia—Methotrexate—esophageal cancer	0.000898	0.00942	CcSEcCtD
Estramustine—Dry skin—Capecitabine—esophageal cancer	0.000897	0.00941	CcSEcCtD
Estramustine—Conjugated Estrogens—ABCC2—esophageal cancer	0.000896	0.0806	CrCbGaD
Estramustine—Estradiol—CYP1B1—esophageal cancer	0.000868	0.0781	CrCbGaD
Estramustine—Tinnitus—Cisplatin—esophageal cancer	0.000857	0.00898	CcSEcCtD
Estramustine—ABCB1—digestive system—esophageal cancer	0.000854	0.00716	CbGeAlD
Estramustine—Flushing—Cisplatin—esophageal cancer	0.000853	0.00894	CcSEcCtD
Estramustine—Thrombophlebitis—Methotrexate—esophageal cancer	0.000842	0.00883	CcSEcCtD
Estramustine—Alopecia—Cisplatin—esophageal cancer	0.000812	0.00851	CcSEcCtD
Estramustine—Abdominal discomfort—Capecitabine—esophageal cancer	0.000811	0.0085	CcSEcCtD
Estramustine—Pancytopenia—Capecitabine—esophageal cancer	0.000804	0.00842	CcSEcCtD
Estramustine—Flatulence—Cisplatin—esophageal cancer	0.000788	0.00826	CcSEcCtD
Estramustine—Muscle spasms—Cisplatin—esophageal cancer	0.000769	0.00806	CcSEcCtD
Estramustine—Depression—Capecitabine—esophageal cancer	0.000752	0.00789	CcSEcCtD
Estramustine—Acute coronary syndrome—Capecitabine—esophageal cancer	0.000744	0.0078	CcSEcCtD
Estramustine—Lethargy—Methotrexate—esophageal cancer	0.000744	0.0078	CcSEcCtD
Estramustine—Cerebrovascular accident—Methotrexate—esophageal cancer	0.000744	0.0078	CcSEcCtD
Estramustine—Myocardial infarction—Capecitabine—esophageal cancer	0.00074	0.00775	CcSEcCtD
Estramustine—Leukopenia—Cisplatin—esophageal cancer	0.000716	0.00751	CcSEcCtD
Estramustine—ABCB1—lung—esophageal cancer	0.000713	0.00598	CbGeAlD
Estramustine—Testosterone—CYP1B1—esophageal cancer	0.000697	0.0626	CrCbGaD
Estramustine—Estriol—ABCB1—esophageal cancer	0.000691	0.0621	CrCbGaD
Estramustine—Mood swings—Methotrexate—esophageal cancer	0.00069	0.00724	CcSEcCtD
Estramustine—Anxiety—Cisplatin—esophageal cancer	0.000679	0.00711	CcSEcCtD
Estramustine—Liver function test abnormal—Methotrexate—esophageal cancer	0.000673	0.00705	CcSEcCtD
Estramustine—Oedema—Cisplatin—esophageal cancer	0.000653	0.00684	CcSEcCtD
Estramustine—Thrombocytopenia—Cisplatin—esophageal cancer	0.000639	0.0067	CcSEcCtD
Estramustine—Tinnitus—Capecitabine—esophageal cancer	0.000632	0.00662	CcSEcCtD
Estramustine—Flushing—Capecitabine—esophageal cancer	0.000629	0.00659	CcSEcCtD
Estramustine—Anorexia—Cisplatin—esophageal cancer	0.000622	0.00652	CcSEcCtD
Estramustine—Abdominal discomfort—Methotrexate—esophageal cancer	0.000604	0.00633	CcSEcCtD
Estramustine—Alopecia—Capecitabine—esophageal cancer	0.000599	0.00627	CcSEcCtD
Estramustine—Pancytopenia—Methotrexate—esophageal cancer	0.000598	0.00627	CcSEcCtD
Estramustine—Dyspnoea—Cisplatin—esophageal cancer	0.000582	0.0061	CcSEcCtD
Estramustine—Flatulence—Capecitabine—esophageal cancer	0.000581	0.00609	CcSEcCtD
Estramustine—Erectile dysfunction—Methotrexate—esophageal cancer	0.00058	0.00608	CcSEcCtD
Estramustine—Decreased appetite—Cisplatin—esophageal cancer	0.000567	0.00595	CcSEcCtD
Estramustine—Muscle spasms—Capecitabine—esophageal cancer	0.000567	0.00594	CcSEcCtD
Estramustine—Depression—Methotrexate—esophageal cancer	0.00056	0.00587	CcSEcCtD
Estramustine—Leukopenia—Capecitabine—esophageal cancer	0.000528	0.00553	CcSEcCtD
Estramustine—Testosterone—CYP19A1—esophageal cancer	0.000511	0.046	CrCbGaD
Estramustine—Chest pain—Capecitabine—esophageal cancer	0.000502	0.00526	CcSEcCtD
Estramustine—Anxiety—Capecitabine—esophageal cancer	0.0005	0.00524	CcSEcCtD
Estramustine—ABCB1—lymph node—esophageal cancer	0.000488	0.00409	CbGeAlD
Estramustine—Oedema—Capecitabine—esophageal cancer	0.000481	0.00504	CcSEcCtD
Estramustine—Thrombocytopenia—Capecitabine—esophageal cancer	0.000471	0.00494	CcSEcCtD
Estramustine—Tinnitus—Methotrexate—esophageal cancer	0.00047	0.00493	CcSEcCtD
Estramustine—Anorexia—Capecitabine—esophageal cancer	0.000459	0.00481	CcSEcCtD
Estramustine—Diarrhoea—Cisplatin—esophageal cancer	0.000447	0.00468	CcSEcCtD
Estramustine—Alopecia—Methotrexate—esophageal cancer	0.000446	0.00467	CcSEcCtD
Estramustine—Insomnia—Capecitabine—esophageal cancer	0.000435	0.00456	CcSEcCtD
Estramustine—Dyspnoea—Capecitabine—esophageal cancer	0.000429	0.0045	CcSEcCtD
Estramustine—Decreased appetite—Capecitabine—esophageal cancer	0.000418	0.00438	CcSEcCtD
Estramustine—Vomiting—Cisplatin—esophageal cancer	0.000415	0.00435	CcSEcCtD
Estramustine—Rash—Cisplatin—esophageal cancer	0.000412	0.00431	CcSEcCtD
Estramustine—Dermatitis—Cisplatin—esophageal cancer	0.000411	0.00431	CcSEcCtD
Estramustine—Leukopenia—Methotrexate—esophageal cancer	0.000393	0.00412	CcSEcCtD
Estramustine—Nausea—Cisplatin—esophageal cancer	0.000388	0.00406	CcSEcCtD
Estramustine—Ethinyl Estradiol—ABCB1—esophageal cancer	0.000377	0.0339	CrCbGaD
Estramustine—Chest pain—Methotrexate—esophageal cancer	0.000374	0.00392	CcSEcCtD
Estramustine—Thrombocytopenia—Methotrexate—esophageal cancer	0.000351	0.00368	CcSEcCtD
Estramustine—Anorexia—Methotrexate—esophageal cancer	0.000341	0.00358	CcSEcCtD
Estramustine—Pruritus—Capecitabine—esophageal cancer	0.00034	0.00357	CcSEcCtD
Estramustine—Conjugated Estrogens—ABCB1—esophageal cancer	0.00033	0.0296	CrCbGaD
Estramustine—Diarrhoea—Capecitabine—esophageal cancer	0.000329	0.00345	CcSEcCtD
Estramustine—Estrone—ABCB1—esophageal cancer	0.000329	0.0296	CrCbGaD
Estramustine—Insomnia—Methotrexate—esophageal cancer	0.000324	0.0034	CcSEcCtD
Estramustine—Dyspnoea—Methotrexate—esophageal cancer	0.000319	0.00335	CcSEcCtD
Estramustine—Decreased appetite—Methotrexate—esophageal cancer	0.000311	0.00326	CcSEcCtD
Estramustine—Vomiting—Capecitabine—esophageal cancer	0.000306	0.00321	CcSEcCtD
Estramustine—Rash—Capecitabine—esophageal cancer	0.000303	0.00318	CcSEcCtD
Estramustine—Dermatitis—Capecitabine—esophageal cancer	0.000303	0.00318	CcSEcCtD
Estramustine—Headache—Capecitabine—esophageal cancer	0.000301	0.00316	CcSEcCtD
Estramustine—Nausea—Capecitabine—esophageal cancer	0.000286	0.003	CcSEcCtD
Estramustine—Pruritus—Methotrexate—esophageal cancer	0.000253	0.00266	CcSEcCtD
Estramustine—Estradiol—ABCB1—esophageal cancer	0.000249	0.0224	CrCbGaD
Estramustine—Diarrhoea—Methotrexate—esophageal cancer	0.000245	0.00257	CcSEcCtD
Estramustine—CYP3A4—Tryptophan metabolism—CYP19A1—esophageal cancer	0.000242	0.00141	CbGpPWpGaD
Estramustine—ESR1—Plasma membrane estrogen receptor signaling—PIK3CA—esophageal cancer	0.00024	0.0014	CbGpPWpGaD
Estramustine—ESR2—Integrated Pancreatic Cancer Pathway—BCL2—esophageal cancer	0.000238	0.00139	CbGpPWpGaD
Estramustine—ESR1—Integrated Breast Cancer Pathway—BAX—esophageal cancer	0.000238	0.00139	CbGpPWpGaD
Estramustine—ESR1—Regulation of Telomerase—CCND1—esophageal cancer	0.000235	0.00137	CbGpPWpGaD
Estramustine—ESR2—Integrated Pancreatic Cancer Pathway—ERBB2—esophageal cancer	0.000231	0.00135	CbGpPWpGaD
Estramustine—ESR1—AP-1 transcription factor network—CCND1—esophageal cancer	0.00023	0.00134	CbGpPWpGaD
Estramustine—Vomiting—Methotrexate—esophageal cancer	0.000228	0.00239	CcSEcCtD
Estramustine—ESR1—Validated nuclear estrogen receptor alpha network—EP300—esophageal cancer	0.000228	0.00132	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—BBC3—esophageal cancer	0.000227	0.00132	CbGpPWpGaD
Estramustine—ESR2—Integrated Pancreatic Cancer Pathway—PTGS2—esophageal cancer	0.000226	0.00132	CbGpPWpGaD
Estramustine—Rash—Methotrexate—esophageal cancer	0.000226	0.00237	CcSEcCtD
Estramustine—Dermatitis—Methotrexate—esophageal cancer	0.000226	0.00237	CcSEcCtD
Estramustine—Headache—Methotrexate—esophageal cancer	0.000224	0.00235	CcSEcCtD
Estramustine—ESR1—LKB1 signaling events—TP53—esophageal cancer	0.000224	0.0013	CbGpPWpGaD
Estramustine—CYP3A4—Phase 1 - Functionalization of compounds—ALDH2—esophageal cancer	0.000223	0.0013	CbGpPWpGaD
Estramustine—ESR2—SIDS Susceptibility Pathways—EP300—esophageal cancer	0.000221	0.00129	CbGpPWpGaD
Estramustine—ESR1—Generic Transcription Pathway—NR1I2—esophageal cancer	0.000219	0.00127	CbGpPWpGaD
Estramustine—ESR1—Leptin signaling pathway—CCND1—esophageal cancer	0.000218	0.00127	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—ABL1—esophageal cancer	0.000215	0.00125	CbGpPWpGaD
Estramustine—Nausea—Methotrexate—esophageal cancer	0.000213	0.00223	CcSEcCtD
Estramustine—ESR1—AP-1 transcription factor network—EP300—esophageal cancer	0.000212	0.00123	CbGpPWpGaD
Estramustine—ABCB1—HIF-1-alpha transcription factor network—HIF1A—esophageal cancer	0.000211	0.00123	CbGpPWpGaD
Estramustine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A6—esophageal cancer	0.00021	0.00122	CbGpPWpGaD
Estramustine—ESR2—Gene Expression—NR1I2—esophageal cancer	0.000209	0.00122	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—SMAD4—esophageal cancer	0.000208	0.00121	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—ABCB1—esophageal cancer	0.000208	0.00121	CbGpPWpGaD
Estramustine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—esophageal cancer	0.000208	0.00121	CbGpPWpGaD
Estramustine—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—esophageal cancer	0.000206	0.0012	CbGpPWpGaD
Estramustine—ESR2—Generic Transcription Pathway—SMAD4—esophageal cancer	0.000205	0.0012	CbGpPWpGaD
Estramustine—ESR2—Integrated Pancreatic Cancer Pathway—CCND1—esophageal cancer	0.000204	0.00119	CbGpPWpGaD
Estramustine—Testosterone—ABCB1—esophageal cancer	0.0002	0.018	CrCbGaD
Estramustine—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—esophageal cancer	0.000199	0.00116	CbGpPWpGaD
Estramustine—ESR1—Validated nuclear estrogen receptor alpha network—MYC—esophageal cancer	0.000198	0.00115	CbGpPWpGaD
Estramustine—ESR1—Regulation of nuclear SMAD2/3 signaling—CDKN1A—esophageal cancer	0.000198	0.00115	CbGpPWpGaD
Estramustine—ESR2—Integrated Pancreatic Cancer Pathway—CDKN1A—esophageal cancer	0.000198	0.00115	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—BAX—esophageal cancer	0.000197	0.00115	CbGpPWpGaD
Estramustine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—esophageal cancer	0.000196	0.00114	CbGpPWpGaD
Estramustine—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—esophageal cancer	0.000193	0.00113	CbGpPWpGaD
Estramustine—ABCB1—HIF-1-alpha transcription factor network—NOS2—esophageal cancer	0.000192	0.00112	CbGpPWpGaD
Estramustine—CYP3A4—Biological oxidations—ADH7—esophageal cancer	0.000192	0.00112	CbGpPWpGaD
Estramustine—ESR1—Regulation of Telomerase—MYC—esophageal cancer	0.000189	0.0011	CbGpPWpGaD
Estramustine—ESR1—Regulation of nuclear SMAD2/3 signaling—EP300—esophageal cancer	0.000188	0.0011	CbGpPWpGaD
Estramustine—ESR2—Integrated Pancreatic Cancer Pathway—EP300—esophageal cancer	0.000188	0.0011	CbGpPWpGaD
Estramustine—ESR1—Regulation of Telomerase—EGFR—esophageal cancer	0.000185	0.00108	CbGpPWpGaD
Estramustine—ESR1—AP-1 transcription factor network—MYC—esophageal cancer	0.000185	0.00107	CbGpPWpGaD
Estramustine—ESR2—Gene Expression—HIST1H2BM—esophageal cancer	0.000179	0.00104	CbGpPWpGaD
Estramustine—ABCB1—HIF-1-alpha transcription factor network—CREBBP—esophageal cancer	0.000172	0.001	CbGpPWpGaD
Estramustine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—esophageal cancer	0.000169	0.000983	CbGpPWpGaD
Estramustine—ESR1—Integrated Breast Cancer Pathway—CASP8—esophageal cancer	0.000169	0.000983	CbGpPWpGaD
Estramustine—CYP3A4—Biological oxidations—ADH1B—esophageal cancer	0.000168	0.000978	CbGpPWpGaD
Estramustine—ESR1—Integrated Breast Cancer Pathway—RB1—esophageal cancer	0.000167	0.000975	CbGpPWpGaD
Estramustine—ESR1—Regulation of nuclear SMAD2/3 signaling—MYC—esophageal cancer	0.000164	0.000956	CbGpPWpGaD
Estramustine—ESR2—Integrated Pancreatic Cancer Pathway—MYC—esophageal cancer	0.000164	0.000954	CbGpPWpGaD
Estramustine—ESR2—Integrated Pancreatic Cancer Pathway—EGFR—esophageal cancer	0.00016	0.000934	CbGpPWpGaD
Estramustine—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—esophageal cancer	0.000159	0.000924	CbGpPWpGaD
Estramustine—CYP3A4—Biological oxidations—CYP26A1—esophageal cancer	0.000156	0.000909	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—ANXA1—esophageal cancer	0.000154	0.000899	CbGpPWpGaD
Estramustine—CYP3A4—Metapathway biotransformation—CYP26A1—esophageal cancer	0.000154	0.000897	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—GDI2—esophageal cancer	0.000153	0.000893	CbGpPWpGaD
Estramustine—ESR1—AP-1 transcription factor network—TP53—esophageal cancer	0.000152	0.000882	CbGpPWpGaD
Estramustine—ESR2—Generic Transcription Pathway—NOTCH1—esophageal cancer	0.000151	0.000881	CbGpPWpGaD
Estramustine—ABCB1—Allograft Rejection—CASP8—esophageal cancer	0.00015	0.000873	CbGpPWpGaD
Estramustine—CYP3A4—Biological oxidations—GSTO1—esophageal cancer	0.000145	0.000845	CbGpPWpGaD
Estramustine—ESR1—Integrated Breast Cancer Pathway—BCL2—esophageal cancer	0.000145	0.000844	CbGpPWpGaD
Estramustine—CYP3A4—Metapathway biotransformation—GSTO1—esophageal cancer	0.000143	0.000834	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—BUB1B—esophageal cancer	0.000141	0.000822	CbGpPWpGaD
Estramustine—ESR1—Signaling by ERBB4—ERBB2—esophageal cancer	0.00014	0.000815	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—CASP8—esophageal cancer	0.00014	0.000815	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—CREBBP—esophageal cancer	0.000139	0.000811	CbGpPWpGaD
Estramustine—ESR2—Integrated Pancreatic Cancer Pathway—PIK3CA—esophageal cancer	0.000139	0.00081	CbGpPWpGaD
Estramustine—ESR2—Gene Expression—PSME2—esophageal cancer	0.000139	0.00081	CbGpPWpGaD
Estramustine—ESR2—Gene Expression—PSME1—esophageal cancer	0.000139	0.00081	CbGpPWpGaD
Estramustine—ESR1—Gene Expression—SMG6—esophageal cancer	0.000139	0.00081	CbGpPWpGaD
Estramustine—ESR1—Generic Transcription Pathway—NOTCH3—esophageal cancer	0.000137	0.0008	CbGpPWpGaD
Estramustine—ESR2—Generic Transcription Pathway—CREBBP—esophageal cancer	0.000137	0.000799	CbGpPWpGaD
Estramustine—ESR2—Integrated Pancreatic Cancer Pathway—TP53—esophageal cancer	0.000135	0.000784	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—CHEK2—esophageal cancer	0.000134	0.000782	CbGpPWpGaD
Estramustine—ABCB1—Transmembrane transport of small molecules—SLC10A2—esophageal cancer	0.000134	0.000778	CbGpPWpGaD
Estramustine—ESR2—Gene Expression—NOTCH3—esophageal cancer	0.000131	0.000764	CbGpPWpGaD
Estramustine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—esophageal cancer	0.00013	0.000756	CbGpPWpGaD
Estramustine—ABCB1—Transmembrane transport of small molecules—ATP1B2—esophageal cancer	0.000126	0.000731	CbGpPWpGaD
Estramustine—ESR1—Integrated Breast Cancer Pathway—CCND1—esophageal cancer	0.000124	0.000724	CbGpPWpGaD
Estramustine—ESR1—Generic Transcription Pathway—NOTCH2—esophageal cancer	0.000123	0.000718	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—BCL2—esophageal cancer	0.00012	0.000699	CbGpPWpGaD
Estramustine—ESR1—Signaling by ERBB4—CDKN1A—esophageal cancer	0.00012	0.000697	CbGpPWpGaD
Estramustine—ABCB1—Transmembrane transport of small molecules—SLC39A6—esophageal cancer	0.000119	0.000693	CbGpPWpGaD
Estramustine—CYP3A4—Biological oxidations—ALDH2—esophageal cancer	0.000118	0.000689	CbGpPWpGaD
Estramustine—ESR2—Gene Expression—NOTCH2—esophageal cancer	0.000118	0.000685	CbGpPWpGaD
Estramustine—ABCB1—HIF-1-alpha transcription factor network—EP300—esophageal cancer	0.000117	0.000684	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—ERBB2—esophageal cancer	0.000117	0.000679	CbGpPWpGaD
Estramustine—ESR1—Integrated Breast Cancer Pathway—EP300—esophageal cancer	0.000115	0.000667	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—PTGS2—esophageal cancer	0.000114	0.000664	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—ABL1—esophageal cancer	0.000114	0.000663	CbGpPWpGaD
Estramustine—ABCB1—Transmembrane transport of small molecules—AQP3—esophageal cancer	0.000114	0.000661	CbGpPWpGaD
Estramustine—CYP3A4—Biological oxidations—GSTT1—esophageal cancer	0.000113	0.000656	CbGpPWpGaD
Estramustine—CYP3A4—Biological oxidations—CYP2A6—esophageal cancer	0.000111	0.000648	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—KMT2D—esophageal cancer	0.000111	0.000646	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—SMAD4—esophageal cancer	0.00011	0.000642	CbGpPWpGaD
Estramustine—ABCB1—Transmembrane transport of small molecules—SLC30A7—esophageal cancer	0.000109	0.000634	CbGpPWpGaD
Estramustine—ABCB1—Transmembrane transport of small molecules—ATP4A—esophageal cancer	0.000109	0.000634	CbGpPWpGaD
Estramustine—CYP3A4—Biological oxidations—PTGS1—esophageal cancer	0.000106	0.000614	CbGpPWpGaD
Estramustine—ESR1—Gene Expression—NR1I2—esophageal cancer	0.000105	0.000614	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—BAX—esophageal cancer	0.000104	0.000607	CbGpPWpGaD
Estramustine—ESR1—Generic Transcription Pathway—SMAD4—esophageal cancer	0.000104	0.000603	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—CCND1—esophageal cancer	0.000103	0.0006	CbGpPWpGaD
Estramustine—ESR1—Integrated Breast Cancer Pathway—MYC—esophageal cancer	9.98e-05	0.000581	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—CDKN1A—esophageal cancer	9.97e-05	0.00058	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—ADCYAP1—esophageal cancer	9.89e-05	0.000576	CbGpPWpGaD
Estramustine—ESR2—Gene Expression—SMAD4—esophageal cancer	9.89e-05	0.000576	CbGpPWpGaD
Estramustine—ESR1—Integrated Breast Cancer Pathway—EGFR—esophageal cancer	9.76e-05	0.000568	CbGpPWpGaD
Estramustine—ESR1—Signaling by ERBB4—EGFR—esophageal cancer	9.71e-05	0.000565	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—EP300—esophageal cancer	9.49e-05	0.000552	CbGpPWpGaD
Estramustine—ESR1—Gene Expression—HIST1H2BM—esophageal cancer	9.04e-05	0.000526	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—WWOX—esophageal cancer	9.04e-05	0.000526	CbGpPWpGaD
Estramustine—CYP3A4—Biological oxidations—CYP1B1—esophageal cancer	8.97e-05	0.000522	CbGpPWpGaD
Estramustine—CYP3A4—Metapathway biotransformation—CYP1B1—esophageal cancer	8.85e-05	0.000515	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—FKBP1A—esophageal cancer	8.6e-05	0.000501	CbGpPWpGaD
Estramustine—CYP3A4—Biological oxidations—CYP19A1—esophageal cancer	8.44e-05	0.000491	CbGpPWpGaD
Estramustine—ESR1—Signaling by ERBB4—PIK3CA—esophageal cancer	8.43e-05	0.00049	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—WIF1—esophageal cancer	8.41e-05	0.000489	CbGpPWpGaD
Estramustine—CYP3A4—Metapathway biotransformation—CYP19A1—esophageal cancer	8.32e-05	0.000484	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—MYC—esophageal cancer	8.27e-05	0.000481	CbGpPWpGaD
Estramustine—ABCB1—Transmembrane transport of small molecules—ABCC2—esophageal cancer	8.25e-05	0.00048	CbGpPWpGaD
Estramustine—ESR1—Integrated Breast Cancer Pathway—TP53—esophageal cancer	8.19e-05	0.000477	CbGpPWpGaD
Estramustine—ESR2—Generic Transcription Pathway—MYC—esophageal cancer	8.14e-05	0.000474	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—EGFR—esophageal cancer	8.09e-05	0.000471	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—CSNK1A1—esophageal cancer	7.76e-05	0.000452	CbGpPWpGaD
Estramustine—ESR1—Generic Transcription Pathway—NOTCH1—esophageal cancer	7.63e-05	0.000444	CbGpPWpGaD
Estramustine—ABCB1—Transmembrane transport of small molecules—GNG7—esophageal cancer	7.49e-05	0.000436	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—esophageal cancer	7.4e-05	0.000431	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—CREBBP—esophageal cancer	7.37e-05	0.000429	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—SLC52A3—esophageal cancer	7.36e-05	0.000428	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—BLVRB—esophageal cancer	7.36e-05	0.000428	CbGpPWpGaD
Estramustine—ESR2—Gene Expression—NOTCH1—esophageal cancer	7.29e-05	0.000424	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—PFN1—esophageal cancer	7.26e-05	0.000422	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—PIK3CA—esophageal cancer	7.02e-05	0.000409	CbGpPWpGaD
Estramustine—ESR1—Gene Expression—PSME2—esophageal cancer	7.02e-05	0.000408	CbGpPWpGaD
Estramustine—ESR1—Gene Expression—PSME1—esophageal cancer	7.02e-05	0.000408	CbGpPWpGaD
Estramustine—ESR1—Generic Transcription Pathway—CREBBP—esophageal cancer	6.92e-05	0.000403	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—TP53—esophageal cancer	6.79e-05	0.000395	CbGpPWpGaD
Estramustine—ESR1—Gene Expression—NOTCH3—esophageal cancer	6.62e-05	0.000385	CbGpPWpGaD
Estramustine—ESR2—Gene Expression—CREBBP—esophageal cancer	6.61e-05	0.000385	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—ELMO1—esophageal cancer	6.52e-05	0.000379	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—AKAP13—esophageal cancer	6.37e-05	0.000371	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—esophageal cancer	6.35e-05	0.00037	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—CA1—esophageal cancer	6.26e-05	0.000364	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—SLC10A2—esophageal cancer	6.26e-05	0.000364	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—esophageal cancer	6.17e-05	0.000359	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—esophageal cancer	6.04e-05	0.000351	CbGpPWpGaD
Estramustine—ESR1—Gene Expression—NOTCH2—esophageal cancer	5.94e-05	0.000346	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—HIST1H2BM—esophageal cancer	5.88e-05	0.000342	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—PDE4D—esophageal cancer	5.83e-05	0.000339	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—CA2—esophageal cancer	5.72e-05	0.000333	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—GNG7—esophageal cancer	5.54e-05	0.000323	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—esophageal cancer	5.45e-05	0.000317	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—ADH7—esophageal cancer	5.32e-05	0.00031	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—PLCE1—esophageal cancer	5.32e-05	0.00031	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—esophageal cancer	5.28e-05	0.000307	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—XIAP—esophageal cancer	5.19e-05	0.000302	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—esophageal cancer	5.02e-05	0.000292	CbGpPWpGaD
Estramustine—ESR1—Gene Expression—SMAD4—esophageal cancer	4.99e-05	0.00029	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—CTNNA1—esophageal cancer	4.91e-05	0.000286	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—CXCL2—esophageal cancer	4.88e-05	0.000284	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—ADH1B—esophageal cancer	4.66e-05	0.000272	CbGpPWpGaD
Estramustine—ABCB1—Transmembrane transport of small molecules—HMOX1—esophageal cancer	4.56e-05	0.000266	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—PSME1—esophageal cancer	4.56e-05	0.000266	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—PSME2—esophageal cancer	4.56e-05	0.000266	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—ANXA1—esophageal cancer	4.54e-05	0.000264	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—SLC52A3—esophageal cancer	4.53e-05	0.000264	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—BLVRB—esophageal cancer	4.53e-05	0.000264	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—TYMP—esophageal cancer	4.46e-05	0.000259	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—SST—esophageal cancer	4.42e-05	0.000257	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—esophageal cancer	4.37e-05	0.000255	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—CYP26A1—esophageal cancer	4.34e-05	0.000252	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—NOTCH3—esophageal cancer	4.3e-05	0.000251	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—GHRL—esophageal cancer	4.3e-05	0.000251	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—esophageal cancer	4.28e-05	0.000249	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—FBXW7—esophageal cancer	4.23e-05	0.000246	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—ALOX15—esophageal cancer	4.23e-05	0.000246	CbGpPWpGaD
Estramustine—ESR1—Generic Transcription Pathway—MYC—esophageal cancer	4.11e-05	0.000239	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—TPI1—esophageal cancer	4.03e-05	0.000235	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—GSTO1—esophageal cancer	4.03e-05	0.000235	CbGpPWpGaD
Estramustine—ESR2—Gene Expression—MYC—esophageal cancer	3.92e-05	0.000228	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—ALDOB—esophageal cancer	3.86e-05	0.000225	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—NOTCH2—esophageal cancer	3.86e-05	0.000225	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—CA1—esophageal cancer	3.85e-05	0.000224	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—SLC10A2—esophageal cancer	3.85e-05	0.000224	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—GAPDH—esophageal cancer	3.72e-05	0.000217	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—esophageal cancer	3.71e-05	0.000216	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—CRABP1—esophageal cancer	3.69e-05	0.000215	CbGpPWpGaD
Estramustine—ESR1—Gene Expression—NOTCH1—esophageal cancer	3.67e-05	0.000214	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—esophageal cancer	3.59e-05	0.000209	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—CA2—esophageal cancer	3.53e-05	0.000205	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—GNG7—esophageal cancer	3.51e-05	0.000204	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—TGFBR2—esophageal cancer	3.42e-05	0.000199	CbGpPWpGaD
Estramustine—ESR1—Gene Expression—CREBBP—esophageal cancer	3.33e-05	0.000194	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—ALDH2—esophageal cancer	3.29e-05	0.000191	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—PLCE1—esophageal cancer	3.28e-05	0.000191	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—ADH7—esophageal cancer	3.28e-05	0.000191	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—SMAD4—esophageal cancer	3.24e-05	0.000189	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—GSTT1—esophageal cancer	3.13e-05	0.000182	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—CYP2A6—esophageal cancer	3.09e-05	0.00018	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—PTGS1—esophageal cancer	2.93e-05	0.000171	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—ENO1—esophageal cancer	2.93e-05	0.000171	CbGpPWpGaD
Estramustine—ABCB1—Transmembrane transport of small molecules—CREBBP—esophageal cancer	2.93e-05	0.00017	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—PSME1—esophageal cancer	2.89e-05	0.000168	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—PSME2—esophageal cancer	2.89e-05	0.000168	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—ADH1B—esophageal cancer	2.87e-05	0.000167	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—TYMP—esophageal cancer	2.75e-05	0.00016	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—CYP26A1—esophageal cancer	2.67e-05	0.000156	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—HIF1A—esophageal cancer	2.65e-05	0.000154	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—ALOX15—esophageal cancer	2.6e-05	0.000152	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—KDR—esophageal cancer	2.54e-05	0.000148	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—CYP1B1—esophageal cancer	2.49e-05	0.000145	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—GSTO1—esophageal cancer	2.48e-05	0.000145	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—TPI1—esophageal cancer	2.48e-05	0.000145	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—NOTCH1—esophageal cancer	2.39e-05	0.000139	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—ALDOB—esophageal cancer	2.38e-05	0.000139	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—CYP19A1—esophageal cancer	2.34e-05	0.000136	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—GAPDH—esophageal cancer	2.29e-05	0.000133	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—CRABP1—esophageal cancer	2.27e-05	0.000132	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—CREBBP—esophageal cancer	2.17e-05	0.000126	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—GNG7—esophageal cancer	2.16e-05	0.000126	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—HMOX1—esophageal cancer	2.14e-05	0.000124	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—ALDH2—esophageal cancer	2.02e-05	0.000118	CbGpPWpGaD
Estramustine—ESR1—Gene Expression—MYC—esophageal cancer	1.98e-05	0.000115	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—NOS3—esophageal cancer	1.94e-05	0.000113	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—GSTT1—esophageal cancer	1.93e-05	0.000112	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—CYP2A6—esophageal cancer	1.9e-05	0.000111	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—ERBB2—esophageal cancer	1.81e-05	0.000106	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—ENO1—esophageal cancer	1.8e-05	0.000105	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—PTGS1—esophageal cancer	1.8e-05	0.000105	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—PSME2—esophageal cancer	1.78e-05	0.000104	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—PSME1—esophageal cancer	1.78e-05	0.000104	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—CCND1—esophageal cancer	1.6e-05	9.33e-05	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—CDKN1A—esophageal cancer	1.55e-05	9.03e-05	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—CYP1B1—esophageal cancer	1.53e-05	8.93e-05	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—EP300—esophageal cancer	1.48e-05	8.59e-05	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—CYP19A1—esophageal cancer	1.44e-05	8.4e-05	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—CREBBP—esophageal cancer	1.37e-05	7.98e-05	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—HMOX1—esophageal cancer	1.32e-05	7.66e-05	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—MYC—esophageal cancer	1.29e-05	7.48e-05	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—ABCB1—esophageal cancer	1.26e-05	7.36e-05	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—EGFR—esophageal cancer	1.26e-05	7.32e-05	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—NOS3—esophageal cancer	1.23e-05	7.14e-05	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—PTGS2—esophageal cancer	1.12e-05	6.53e-05	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—PIK3CA—esophageal cancer	1.09e-05	6.35e-05	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—TP53—esophageal cancer	1.06e-05	6.15e-05	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—EP300—esophageal cancer	9.34e-06	5.43e-05	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—CREBBP—esophageal cancer	8.44e-06	4.92e-05	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—NOS3—esophageal cancer	7.56e-06	4.4e-05	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—PTGS2—esophageal cancer	6.92e-06	4.03e-05	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—PIK3CA—esophageal cancer	6.91e-06	4.02e-05	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—EP300—esophageal cancer	5.75e-06	3.35e-05	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—PIK3CA—esophageal cancer	4.25e-06	2.48e-05	CbGpPWpGaD
